Artículo
SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy
Fecha de publicación:
02/2021
Editorial:
Elsevier Science Inc.
Revista:
Lancet Neurology
ISSN:
1474-4422
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
During the pandemic it has become clear that severe acure respiratory syndrome coronavirus (SARS-CoV-2) causes not just respiratory disease, but can affect multiple organs and tissues. Of note is the involvement of the CNS and PNS, and the fact that this involvement is independent from the severity of the respiratory disease. Acute and subacute neurological complications of SARS-CoV-2 infections are reported in up to 85% of patients, including those with severe COVID-19, but also in otherwise minimally symptomatic or asymptomatic people. As many as 65% of people with COVID-19 present with hyposmia, which is also a common premotor symptom in Parkinson’s disease. This symptom, added to the fact that parkinsonism has been reported following COVID-19, has drawn the attention of the medical community to the hypothetical link between SARS-CoV-2 infection and Parkinson’s disease.
Palabras clave:
PARKINSON
,
COVID-19
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Articulos de SEDE CENTRAL
Citación
Merello, Marcelo Jorge; Bhatia, Kailash P.; Obeso, Jose A.; SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy; Elsevier Science Inc.; Lancet Neurology; 20; 2; 2-2021; 94-95
Compartir
Altmétricas